Ganina S S, Ragimov Ch R
Stomatologiia (Mosk). 1991 Nov-Dec(6):28-30.
Dalargin was used in therapy of patients with phlegmons of the face and neck. The treatment efficacy was assessed by analyzing the parameters of the peripheral blood free-radical oxidation and clinical data. The main group (n = 38) patients with medium-severe or severe course of the process were administered dalargin as part of a therapeutic complex; such therapy resulted in early arrest of the inflammatory process and recovery of the reliable correlation between the major parameters of lipid peroxidation and antioxidant systems. These correlations were shifted in the reference group (26 patients), and inflammatory processes in the wound lasted longer in them.
达乐argin用于治疗面部和颈部蜂窝织炎患者。通过分析外周血自由基氧化参数和临床数据来评估治疗效果。主要组(n = 38)患有中度 - 重度或重度病程的患者接受达乐argin作为综合治疗的一部分;这种治疗导致炎症过程早期停止,并使脂质过氧化和抗氧化系统的主要参数之间恢复可靠的相关性。在参照组(26名患者)中,这些相关性发生了变化,伤口的炎症过程持续时间更长。